Search results
Robert Kennedy Jr. Is Sorry the FDA Didn't Approve Psychedelic Drug MDMA (Ecstasy or Molly) for PTSD...
Showbiz411· 9 hours agoWhat is our potential next president worried about? Robert Kennedy Jr — just kidding– never to be...
US FDA warns on risks linked to sulfite-containing compounded drugs
Reuters via Yahoo News· 12 hours agobreathing difficulty with low blood oxygen, potentially related to sulfite-containing compounded...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 13 hours agoThe CDC’s Advisory Committee on Immunization Practice will meet in late June to discuss...
MDMA drug for PTSD panned by FDA advisers citing trial flaws - The Boston Globe
The Boston Globe· 14 hours agoAdvisers to the Food and Drug Administration voted 9 to 2 that developer Lykos Therapeutics Inc.’s...
FDA Advisors Recommend Against Using MDMA for PTSD Treatment
Time via Yahoo News· 16 hours agoFDA approved the first human trial that looked at whether MDMA could relieve pain for those who were...
An FDA panel just rejected using MDMA to treat PTSD. Here are 5 things to know about the psychedelic...
Yahoo Life Style via AOL· 15 hours agoMDMA, also known as ecstasy, is seen by some experts as a potential breakthrough treatment for PTSD,...
FDA Advisers Overwhelmingly Oppose Approval of MDMA As a Psychotherapeutic Catalyst
Reason.com via AOL· 14 hours ago"We remain committed to working with the FDA to address outstanding questions so that we may find a...
The FDA should stop letting drug companies skip steps - The Boston Globe
The Boston Globe· 2 days agoThis is a valuable alternative to the lengthy traditional approval process, but it comes with the...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 13 hours agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
Psychedelic Drug Stocks Plummet On FDA Advisers' Doubts About Ecstasy Candidate
The Wall Street Journal· 18 hours agoThe stocks fell after experts advising the FDA on Tuesday evening voted against a drug application...